Capital Research Global Investors Makes New Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Capital Research Global Investors acquired a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 408,048 shares of the company’s stock, valued at approximately $51,149,000.

Other institutional investors also recently modified their holdings of the company. Summit Place Financial Advisors LLC lifted its holdings in shares of Addus HomeCare by 0.9% in the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company’s stock valued at $1,180,000 after purchasing an additional 80 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock valued at $1,340,000 after acquiring an additional 91 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company’s stock worth $2,465,000 after acquiring an additional 91 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in shares of Addus HomeCare by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company’s stock valued at $742,000 after purchasing an additional 150 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on ADUS shares. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. JMP Securities reaffirmed a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Thursday, April 10th. Macquarie reissued an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, Stephens reaffirmed an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $97.28 on Tuesday. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72. The business’s fifty day moving average is $99.11 and its 200 day moving average is $116.78. The firm has a market cap of $1.77 billion, a price-to-earnings ratio of 22.26, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.